Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma

Research output: Contribution to journalReview articlepeer-review


Neuroblastoma (NB) and malignant melanoma (MM), tumors of pediatric age and adulthood, respectively, share a common origin, both of them deriving from the neural crest cells. Although NB and MM have a different behavior, in respect to age of onset, primary tissue involvement and metastatic spread, the prognosis for high stage-affected patients is still poor, in spite of aggressive treatment strategies and the huge amount of new discovered biological knowledge. For these reasons researchers are continuously attempting to find out new treatment options, which in a near future could be translated to the clinical practice. In the last two decades, a strong effort has been spent in the field of translational research of immunotherapy which led to satisfactory results. Indeed, several immunotherapeutic clinical trials have been performed and some of them also resulted beneficial. Here, we summarize preclinical studies based on immunotherapeutic approaches applied in models of both NB and MM.

Original languageEnglish
Pages (from-to)8097398
JournalJournal of Immunology Research
Publication statusPublished - 2018


  • Adult
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Child
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Humans
  • Immunotherapy/methods
  • Melanoma/immunology
  • Neural Crest/pathology
  • Neuroblastoma/immunology
  • Remission Induction
  • Translational Medical Research


Dive into the research topics of 'Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma'. Together they form a unique fingerprint.

Cite this